89 related articles for article (PubMed ID: 22119383)
1. Mechanistic role of p38 MAPK in gastric cancer dissemination in a rodent model peritoneal metastasis.
Graziosi L; Mencarelli A; Santorelli C; Renga B; Cipriani S; Cavazzoni E; Palladino G; Laufer S; Burnet M; Donini A; Fiorucci S
Eur J Pharmacol; 2012 Jan; 674(2-3):143-52. PubMed ID: 22119383
[TBL] [Abstract][Full Text] [Related]
2. Gene expression changes induced by HIPEC in a murine model of gastric cancer.
Graziosi L; Mencarelli A; Renga B; Santorelli C; Cantarella F; Bugiantella W; Cavazzoni E; Donini A; Fiorucci S
In Vivo; 2012; 26(1):39-45. PubMed ID: 22210714
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of p38-MAPK potentiates cisplatin-induced apoptosis via GSH depletion and increases intracellular drug accumulation in growth-arrested kidney tubular epithelial cells.
Rodríguez-García ME; Quiroga AG; Castro J; Ortiz A; Aller P; Mata F
Toxicol Sci; 2009 Oct; 111(2):413-23. PubMed ID: 19578154
[TBL] [Abstract][Full Text] [Related]
4. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
[TBL] [Abstract][Full Text] [Related]
5. Development and biological analysis of peritoneal metastasis mouse models for human scirrhous stomach cancer.
Yanagihara K; Takigahira M; Tanaka H; Komatsu T; Fukumoto H; Koizumi F; Nishio K; Ochiya T; Ino Y; Hirohashi S
Cancer Sci; 2005 Jun; 96(6):323-32. PubMed ID: 15958054
[TBL] [Abstract][Full Text] [Related]
6. A novel transforming growth factor beta receptor kinase inhibitor, A-77, prevents the peritoneal dissemination of scirrhous gastric carcinoma.
Kawajiri H; Yashiro M; Shinto O; Nakamura K; Tendo M; Takemura S; Node M; Hamashima Y; Kajimoto T; Sawada T; Ohira M; Hirakawa K
Clin Cancer Res; 2008 May; 14(9):2850-60. PubMed ID: 18451253
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of nuclear factor-kappaB suppresses peritoneal dissemination of gastric cancer by blocking cancer cell adhesion.
Mino K; Ozaki M; Nakanishi K; Haga S; Sato M; Kina M; Takahashi M; Takahashi N; Kataoka A; Yanagihara K; Ochiya T; Kamiyama T; Umezawa K; Todo S
Cancer Sci; 2011 May; 102(5):1052-8. PubMed ID: 21288284
[TBL] [Abstract][Full Text] [Related]
8. Activation of p38 mitogen-activated protein kinase abolishes insulin-mediated myocardial protection against ischemia-reperfusion injury.
Chai W; Wu Y; Li G; Cao W; Yang Z; Liu Z
Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E183-9. PubMed ID: 18003719
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological Inhibition of p38 MAPK by SB203580 Increases Resistance to Carboplatin in A2780cp Cells and Promotes Growth in Primary Ovarian Cancer Cells.
Han X; Chen H; Zhou J; Steed H; Postovit LM; Fu Y
Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30049957
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and gastrointestinal tolerability of ML3403, a selective inhibitor of p38 MAP kinase and CBS-3595, a dual inhibitor of p38 MAP kinase and phosphodiesterase 4 in CFA-induced arthritis in rats.
Koch DA; Silva RB; de Souza AH; Leite CE; Nicoletti NF; Campos MM; Laufer S; Morrone FB
Rheumatology (Oxford); 2014 Mar; 53(3):425-32. PubMed ID: 24241037
[TBL] [Abstract][Full Text] [Related]
11. Characterization and inhibition of a p38-like mitogen-activated protein kinase (MAPK) from Echinococcus multilocularis: antiparasitic activities of p38 MAPK inhibitors.
Gelmedin V; Caballero-Gamiz R; Brehm K
Biochem Pharmacol; 2008 Oct; 76(9):1068-81. PubMed ID: 18789902
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiological role of the activation of p38 mitogen-activated protein kinases in poorly differentiated gastric cancer.
Atsumi T; Kato K; Uno K; Iijima K; Koike T; Imatani A; Ohara S; Shimosegawa T
Pathol Int; 2007 Oct; 57(10):635-44. PubMed ID: 17803652
[TBL] [Abstract][Full Text] [Related]
13. Establishing a peritoneal dissemination xenograft mouse model for survival outcome assessment of experimental gastric cancer.
Zhang C; Awasthi N; Schwarz MA; Schwarz RE
J Surg Res; 2013 Jun; 182(2):227-34. PubMed ID: 23201270
[TBL] [Abstract][Full Text] [Related]
14. Metformin combined with p38 MAPK inhibitor improves cisplatin sensitivity in cisplatin‑resistant ovarian cancer.
Xie Y; Peng Z; Shi M; Ji M; Guo H; Shi H
Mol Med Rep; 2014 Nov; 10(5):2346-50. PubMed ID: 25118792
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of p38 mitogen-activated protein kinase alters microRNA expression and reverses epithelial-to-mesenchymal transition.
Antoon JW; Nitzchke AM; Martin EC; Rhodes LV; Nam S; Wadsworth S; Salvo VA; Elliott S; Collins-Burow B; Nephew KP; Burow ME
Int J Oncol; 2013 Apr; 42(4):1139-50. PubMed ID: 23403951
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological inhibition of p38 MAPK reduces tumor growth in patient-derived xenografts from colon tumors.
Gupta J; Igea A; Papaioannou M; Lopez-Casas PP; Llonch E; Hidalgo M; Gorgoulis VG; Nebreda AR
Oncotarget; 2015 Apr; 6(11):8539-51. PubMed ID: 25890501
[TBL] [Abstract][Full Text] [Related]
17. CCL2 secreted from cancer-associated mesothelial cells promotes peritoneal metastasis of ovarian cancer cells through the P38-MAPK pathway.
Yasui H; Kajiyama H; Tamauchi S; Suzuki S; Peng Y; Yoshikawa N; Sugiyama M; Nakamura K; Kikkawa F
Clin Exp Metastasis; 2020 Feb; 37(1):145-158. PubMed ID: 31541326
[TBL] [Abstract][Full Text] [Related]
18. Targeting the p38 MAPK pathway inhibits irinotecan resistance in colon adenocarcinoma.
Paillas S; Boissière F; Bibeau F; Denouel A; Mollevi C; Causse A; Denis V; Vezzio-Vié N; Marzi L; Cortijo C; Ait-Arsa I; Askari N; Pourquier P; Martineau P; Del Rio M; Gongora C
Cancer Res; 2011 Feb; 71(3):1041-9. PubMed ID: 21159664
[TBL] [Abstract][Full Text] [Related]
19. AXL Downstream Targeting Unravels Synergistic Drug Combinations in Ovarian Carcinoma Cells.
Alampi DM; Ciusani E; Carenini N; Corna E; Gatti L; Corno C
Anticancer Res; 2019 Jul; 39(7):3803-3808. PubMed ID: 31262907
[TBL] [Abstract][Full Text] [Related]
20. Roles of p38 MAPKs in invasion and metastasis.
del Barco Barrantes I; Nebreda AR
Biochem Soc Trans; 2012 Feb; 40(1):79-84. PubMed ID: 22260669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
